← Back to Clinical Trials
Recruiting NCT06629467

NCT06629467 Cognitive Behavioral Treatment with Activity Trackers for Smoking Cessation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06629467
Status Recruiting
Phase
Sponsor University of Oviedo
Condition Tobacco Use Cessation
Study Type INTERVENTIONAL
Enrollment 128 participants
Start Date 2023-05-10
Primary Completion 2025-12-01

Trial Parameters

Condition Tobacco Use Cessation
Sponsor University of Oviedo
Study Type INTERVENTIONAL
Phase N/A
Enrollment 128
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-05-10
Completion 2025-12-01
Interventions
Cognitive-behavioral therapy for smoking cessationPersonalized PA planFitbit Versa 3

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Given the high prevalence of deaths per year attributable to tobacco use, improving smoking cessation treatments is an important public health priority Worldwide. It is also known that practicing physical activity (PA) may help smoking cessation. Physical activity trackers have been demonstrated to increase PA levels in different studies with various populations, as a sole intervention or in combination with interventions targeting PA. This study aims to examine the feasibility, effect, and cost-effectiveness of cognitive-behavioral therapy (CBT) + Personalized physical activity (PA) + Physical Activity Tracker use (Fitbit Versa 3®) for smoking cessation. Given the high prevalence of deaths per year attributable to tobacco use, improving smoking cessation treatments is an important public health priority worldwide. In this study, an estimated sample of 128 adult smokers will be randomly allocated to one of the following conditions: 1) CBT for smoking cessation + personalized PA plan + Fitbit Versa 3®; 2) CBT for smoking cessation + personalized PA plan. Mail goals: 1) To examine the feasibility (i.e., adherence, perceived utility, satisfaction) of integrating Fitbit Versa 3® into a CBT protocol for smoking cessation; 2) to examine the effectiveness of CBT for smoking cessation + personalized PA plan + Fitbit Versa 3® and CBT for smoking cessation + personalized PA plan in terms of smoking abstinence rates (point-prevalence and days of continuous abstinence), PA (i.e., steps per day, moderate to vigorous physical activity) and mental health outcomes (anxiety and depression symptoms, emotional dysregulation); 3) to examine the cost-effectiveness of CBT for smoking cessation + personalized PA plan + Fitbit Versa 3® vs. CBT for smoking cessation + personalized PA plan in terms of smoking abstinence rates (point-prevalence and days of continuous abstinence), PA (i.e., steps per day, moderate to vigorous physical activity) and mental health outcomes (anxiety and depression symptoms, emotional dysregulation).

Eligibility Criteria

Inclusion Criteria: * Being aged 18 or over. * Smoking at least 10 cigarettes per day. Exclusion Criteria: * Being currently receiving other psychological or pharmacological treatment for smoking cessation. * Being diagnosed with substance use disorder or severe psychiatric disorder. * Active suicidal ideation.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology